{
  "cg:id": "Ex002",
  "cg:type": "Example",
  "dataId": {
    "cg:id": "CritAssess276",
    "cg:type": "CriterionAssessment",
    "criterion": {
      "cg:id": "PVS1",
      "cg:type": "Criterion",
      "description": "null variant (nonsense, frameshift, canonical Â±1 or 2 splice sites, initiation codon, single or multiexon deletion) in a gene where LOF is a known mechanism of disease",
      "shortDescription": "Null variant in gene with known LOF mechanism",
      "defaultStrength": "CG-evidence-strength:pvs",
      "targetInterpretation": "LN:LA6668-3"
    },
    "variant": {
      "cg:id": "CanAll002",
      "cg:type": "CanonicalAllele",
      "preferredCtxAllele": "CtxAll002"
    },
    "condition": [
      {
        "cg:id": "MendCond001",
        "cg:type": "MendelianCondition",
        "explanation": "Breast Ovarian Cancer, Autosomal Dominant",
        "name": "Breast Ovarian Cancer, Autosomal Dominant",
        "disease": [
          "MESH:D061325"
        ],
        "modeOfInheritance": "HP:0000006"
      }
    ],
    "outcome": "CG-criterion-outcome:met",
    "hasSupportingEvidence": [
      {
        "cg:id": "EvLn002",
        "cg:type": "EvidenceLine",
        "supportingData": [
          {
            "cg:id": "MolCon003",
            "cg:type": "MolecularConsequence",
            "explanation": "LOF is predicted to occur as variant is >55bp from penultimate exon",
            "contextualAllele": {
              "cg:id": "CtxAll002",
              "cg:type": "ContextualAllele",
              "relatedCanonicalAllele": {
                "cg:id": "CanAll002",
                "cg:type": "CanonicalAllele",
                "preferredCtxAllele": "CtxAll002"
              },
              "alleleName": "NM_000059.3(BRCA2):c.7762_7764delinsTT"
            },
            "consequence": "SO:0001589",
            "lof": true
          },
          {
            "cg:id": "CondMech004",
            "cg:type": "ConditionMechanism",
            "explanation": "This is so well-known that it does not require a citation.",
            "mechanism": "SO:0002054",
            "strength": "CG-cond-mech-strength:established",
            "gene": {
              "cg:id": "G002",
              "cg:type": "Gene",
              "symbol": "BRCA2"
            },
            "condition": {
              "cg:id": "MendCond001",
              "cg:type": "MendelianCondition",
              "explanation": "Breast Ovarian Cancer, Autosomal Dominant",
              "name": "Breast Ovarian Cancer, Autosomal Dominant",
              "disease": [
                "MESH:D061325"
              ],
              "modeOfInheritance": "HP:0000006"
            }
          }
        ]
      }
    ],
    "contribution": [
      {
        "cg:id": "Contrib397",
        "cg:type": "Contribution",
        "agent": "Harry Stevenson",
        "onDate": {
          "cg:id": "2016-06-02T12:14:59+00:00"
        },
        "role": "CG-contributory-role:assessor"
      }
    ]
  },
  "index": 2,
  "author": "Steven Harrison",
  "description": "Variant: NM_000059.3(BRCA2):c.7762_7764delinsTT (p.I2588Ffs*60)\nPVS1 is applicable for this variant because\na. BRCA2 - LOF is an established disease mechanism for breast ovarian cancer\nb. LOF is predicted to occur as variant is >55bp from penultimate exon"
}
